is a point for discussion if the treatment for fibrosis could be
similar to that used for fibrotic lung disease, e.g. N-acetylcysteine or
novel drugs such as pirfenidone in IPF, but no clinical trials have
been published to date. Immunosuppressive therapy is discouraged when a
diagnosis of IPF has been made.